foerster erskine webcast

040823 1

In Search of Excellence

Director of Investor Relations

Scott Gibson

040823 2


Chairman of the Board

Elliot Voon Pin Chaw

040823 3

Greetings

040823 4

Introduction The Whole New The transformation

69

Global Real Estate

Global Telecommunications

Utilities and Infrastructure

Biotechnology and Life Sciences

Banking and Financial Services

040823 5

Introduction The Whole New Group of Companies

Global Real Estate


Utilities and Energy



040823 6

Introduction The Whole New

After successful transformation new strategic direction is focused on ldquocapital efficient growthrdquo

We all know this is a people business

6931

Public and

Institution Investor

040823 7

Introduction The Whole NewCorporate Profile

Foerster Erskine AG (Previously known as ldquoMathis Corporation AGrdquo)

Substantial Shareholder Chaw Media Group Network Corporation GmbH (ldquoCMGNrdquo)

A conglomerate holding company headquartered in Frankfurt Germany that oversees and

manages a number of subsidiary companies Foerster Erskine is one of Germanys leading multi-

national conglomerates with a diverse array of holdings which includes real estate

telecommunications utilities amp energy life sciences amp biotechnology banking amp financial services

Foerster Erskine is one of a few global firms with highest corporate credit ratings

040823 8

Introduction The Whole NewKey takeaways

Strong foundation

bullAccelerated order intake and stabilizing revenue growth

bullCredit Rating AA

bullFive division named Core Foerster Erskine ndash with profit increasing

bullThirteen subsidiaries are all pioneer and leading player in the respective industry

bullProposed dividend increased to euro 085 one-off payment to employees

bullAll sectors well within the operational margin targets

bullSuccessful implementation in restructure transaction

bullStrengthened balance sheet

bullFramework ldquoCore Foerster Erskinerdquo to accelerate capital efficient growth

040823 9

Introduction The Whole NewStatistics

gt 20 growth in new orders

gt1 growth in 2Q 2011 revenue compare to 1Q 2011 results

Increase profit in ldquoCore Foerster Erskinerdquo

Increase in net profit

Increase in basic earning per share in euro

Increase flexibility in cash flow

040823 10

Introduction The Whole NewOrder Backlog in 4Q 2010

Strong order backlog

(compared to 3Q 2010)

32 in Property Development

10 in Infrastructure Engineering and Construction

29 in Energy Utilities

5 in Life Sciences

24 in Biotechnology products in Retail Stores

040823 11







5 in Life Sciences


Major Orders in 4Q 2010

bullBiotechnology products by retail stores principally Park Link Retail Increase sales in medicine pharmaceutical products skin care healthcare accessories

bullLife Sciences ndash principally in agriculture sectors Asian have strong demanding market on Cabriolet Synapsersquos agriculture system Equipment and Consulting Services

bullEnergy and Utilities ndash Power plants Renewable energy sustainability Eight service contracts worth euro 1541 millioneuro 96billion order to INSPIRATION Technologies Increase revenue in oil and gas sector

bullInfra EampC - euro 520m order in Hamburg ndash Tunnel euro 785m order in oil refinery South East Chinaeuro 3 billion order from Asian developing countries ndash Contracts

bullProperty Development ndash Chariot Development in China Hong Kong Singapore Malaysia Germany Increased sales performance in 4Q 2010 due to economic recovery

040823 12

Introduction The Whole NewFree Cash Flow Generation at exception higher level in 2010

bullCapital Ratio

bullStructural Liquidity

bullLong-term Debt

bullEquity

bullTotal Assets

bullKey Risk Exposures

040823 13

Introduction The Whole NewManagement Organization

Management Board

Supervisory Board

Sector CEOGlobal Real Estate

Sector CEOGlobal Telecommunications

Sector CEOGlobal Utilities and Energy

Sector CEOBiotechnology and Life Sciences

Sector CEOBanking and Financial Services

040823 14

Introduction The Whole NewOverview of New Structure

Sector CEO

Management Board Group of Companies

1 Real-time data transmit

2 Strategy Implementation

3 Marketplace Information Sharing

4 Solution Center

5 Latest Information System

6 Marketplace Position and Market share

040823 15

Introduction The Whole NewValue Recreation

CMGN Acquired Listed Company

Spin Off Subsidiary Companies

Internal Restructure

Commence on DAX Listing

Managementrsquos Business Analyze and Discussion

Strategy Implementation

Increase profitability and market share

Maximize 5 Core Business

Enhanced Seek for new way

040823 16


bull1048599 Returning Foerster Erskine to higher profitability is our top priority

bull1048599 Clients remain active and engaged with Forester Erskine

bull1048599 Industry profitability affected by asset price stabilization

bull1048599 Well positioned to create shareholder value and return to profitability

ndash Large risk capital base ndash bridge to rebuild the foundation

ndash Forester Erskine Core Business Substantial earnings power

ndash Emerging Markets Expected positive value

040823 17


Certain statements in this document are ldquoforward-looking statementsrdquo

within the meaning of the Private Securities Litigation Reform Act

These statements are based on managementrsquos current expectations

and are subject to uncertainty and changes in circumstances Actual

results may differ materially from those included in these statements

due to a variety of factors More information about these factors is

contained in Foerster Erskine AGrsquos filings with the Securities and

Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 2


Chairman of the Board

Elliot Voon Pin Chaw

040823 3

Greetings

040823 4


69

Global Real Estate





040823 5


Global Real Estate





040823 6




6931

Public and


040823 7









040823 8


Strong foundation










040823 9








040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 3

Greetings

040823 4


69

Global Real Estate





040823 5


Global Real Estate





040823 6




6931

Public and


040823 7









040823 8


Strong foundation










040823 9








040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 4


69

Global Real Estate





040823 5


Global Real Estate





040823 6




6931

Public and


040823 7









040823 8


Strong foundation










040823 9








040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 5


Global Real Estate





040823 6




6931

Public and


040823 7









040823 8


Strong foundation










040823 9








040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 6




6931

Public and


040823 7









040823 8


Strong foundation










040823 9








040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 7









040823 8


Strong foundation










040823 9








040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 8


Strong foundation










040823 9








040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 9








040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 10







5 in Life Sciences


040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 11







5 in Life Sciences








040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 12


bullCapital Ratio


bullLong-term Debt

bullEquity

bullTotal Assets


040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 13


Management Board

Supervisory Board






040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 14


Sector CEO





4 Solution Center



040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 15











040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 16









040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

040823 17









Exchange Commission

Slide 1

Slide 2

Slide 3

Slide 4

Slide 5

Slide 6

Slide 7

Slide 8

Slide 9

Slide 10

Slide 11

Slide 12

Slide 13

Slide 14

Slide 15

Slide 16

Slide 17

foerster erskine webcast

Documents

life sciences banking

life sciences 24

foerster erskine

order backlog

property development 10

biotechnology products

energy

utilities 5